Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Concomitant Chemoradiotherapy With Filgrastim for Locoregionally Advanced Head and Neck Cancer
NCT01693718Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Mar 2003
- Primary completion
- Sep 2003
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in head and neck cancer (HNC), sponsored by University of Chicago. Started Mar 2003; status: completed.
02
Drugs
filgrastim
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT01693718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01693718.